Search - tctmd.com

Displaying 521 - 540 of 876

Sort: Relevancy | Date

Presentation TCT 2018

Patient Perspectives on Sham-Controlled Trials

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Debbe McCall

September 23, 2018

Presentation TCT 2018

FDA Perspectives on Sham-Controlled Trials

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Hiren Mistry

September 23, 2018

Presentation TCT 2018

Sham Controls in Renal Denervation Studies: Need to Have vs Nice to Have?

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, David E. Kandzari

September 23, 2018

Presentation TCT 2018

ORBITA One Year Later: What Would I Do Differently, If Anything?

Presenter: Kenneth J. Cavanaugh Jr, Roxana Mehran, Rasha Al-Lamee

September 23, 2018

Presentation TCT 2018

EFS Experiences Grom the Industry Client Perspective: Whats Good and What Needs to Change?

Presenter: Andrew Farb, Martin B. Leon, Donald E. Bobo Jr

September 22, 2018

Presentation TCT 2018

EFS Decisions: Start-up Company Considerations

Presenter: Andrew Farb, Martin B. Leon, Beverly A Huss

September 22, 2018

Presentation TCT 2018

Promoting Medical Device Innovation: MDIC Perspectives

Presenter: Andrew Farb, Martin B. Leon, Liz McDermott

September 22, 2018

Presentation TCT 2018

The Second-Generation Cardiovascular EFS Pilot: Progress Report

Presenter: Andrew Farb, Martin B. Leon, David R. Holmes Jr.

September 22, 2018

Presentation TCT 2018

The US EFS Program: FDA Update

Presenter: Andrew Farb, Martin B. Leon

September 22, 2018

Presentation TCT 2018

Industry Perspective

Presenter: C. Michael Gibson, William H. Maisel, Campbell Rogers

September 22, 2018

Presentation TCT 2018

Clinician Scientist/Trialist Perspective

Presenter: C. Michael Gibson, William H. Maisel, James K. Min

September 22, 2018

Presentation TCT 2018

FDA Perspectives

Presenter: C. Michael Gibson, William H. Maisel, Mohua Choudhury

September 22, 2018

Presentation TCT 2018

Keynote Lecture: The Potential Impact of Machine Learning/Artificial Intelligence on Cardiovascular Medical Device Development

Presenter: C. Michael Gibson, William H. Maisel, Peter J. Fitzgerald

September 22, 2018

Presentation TCT 2018

CMS Perspectives

Presenter: Lori M Ashby

September 22, 2018

Presentation TCT 2018

Clinician Perspectives

Presenter: Megan Coylewright

September 22, 2018

Presentation TCT 2018

Patient-Centered Engagement in Trials: Case Example - ADAPTABLE

Presenter: John C Laschinger, J. Dawn Abbott, Lori M Ashby, Robert A. Byrne, David A. Cox, Mona Fiuzat, Christopher O'Connor, John A. Spertus, Susan Strong

September 22, 2018

Presentation TCT 2018

FDAs Patient Engagement Initiatives: How FDA Can Incorporate Patient Centered and Patient Reported Outcomes in Regulatory Decision-Making

Presenter: John C Laschinger

September 22, 2018

Presentation TCT 2018

Keynote Lecture: FDA/CDRH - The Year in Review

Presenter: Mitchell W. Krucoff, Gregg W. Stone, William H. Maisel

September 22, 2018

Presentation TCT 2018

The TCT FDA Town Hall Meetings in Perspective: A Multidisciplinary Collaborative Venture

Presenter: Mitchell W. Krucoff, Gregg W. Stone, Martin B. Leon

September 22, 2018

Presentation TCT 2018

Training in Endovascular Intervention

Presenter: Jay S. Giri, Sahil A. Parikh

September 22, 2018

Advertisement

Patient Perspectives on Sham-Controlled Trials

FDA Perspectives on Sham-Controlled Trials

Sham Controls in Renal Denervation Studies: Need to Have vs Nice to Have?

ORBITA One Year Later: What Would I Do Differently, If Anything?

EFS Experiences Grom the Industry Client Perspective: Whats Good and What Needs to Change?

EFS Decisions: Start-up Company Considerations

Promoting Medical Device Innovation: MDIC Perspectives

The Second-Generation Cardiovascular EFS Pilot: Progress Report

The US EFS Program: FDA Update

Industry Perspective

Clinician Scientist/Trialist Perspective

FDA Perspectives

Keynote Lecture: The Potential Impact of Machine Learning/Artificial Intelligence on Cardiovascular Medical Device Development

CMS Perspectives

Clinician Perspectives

Patient-Centered Engagement in Trials: Case Example - ADAPTABLE

FDAs Patient Engagement Initiatives: How FDA Can Incorporate Patient Centered and Patient Reported Outcomes in Regulatory Decision-Making

Keynote Lecture: FDA/CDRH - The Year in Review

The TCT FDA Town Hall Meetings in Perspective: A Multidisciplinary Collaborative Venture

Training in Endovascular Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content